Navigation Links
Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Date:6/7/2011

t with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; our reliance on a single product candidate, ENMD-2076; the volatility of our common stock; our history of losses and expectation of incurring continued losses; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; the failure to consummate a transaction to monetize our Thalomid® royalty stream for any reason, including our inability to obtain the required third-party consents; our dependence on a royalty sharing agreement based on sales of a product, Thalomid®, that we do not have control; declines in actual sales of Thalomid® resulting in materially reduced royalty payments; risks associated with our product candidates; results in preclinical models that are not necessarily indicative of clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; any lack of progress of our research and development (including the results of our clinical trials); dependence on third parties; risks relating to the commercialization, if any, of our proposed products (such as marketing, safety, regulatory, patent, product liability, supply and other risks); and our ability to compete with larger, better financed biotechnology companies that may develop new approaches to the treatment of our targeted diseases. Additio
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
4. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
5. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
6. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: ... meeting of stockholders held today, the Company,s stockholders adopted ... and among the Company, Healthy Harmony Holdings, L.P. ("Parent"), ... an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) Co., ... CEO of the Company. The Merger Agreement ...
(Date:9/16/2014)... KANSAS CITY, Kan. , Sept. 16, 2014 ... ), a pet therapeutics company focused on licensing, ... animals, today announced that it is commencing an ... common stock.  All of the shares are being ... LLC and Barclays are acting as joint book-running ...
(Date:9/16/2014)... , Sept. 16, 2014  This report analyzes the ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Aratana Therapeutics, Inc. Announces Proposed Public Offering 2Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8Global Digital Radiography Industry 9Global Digital Radiography Industry 10Global Digital Radiography Industry 11Global Digital Radiography Industry 12Global Digital Radiography Industry 13Global Digital Radiography Industry 14Global Digital Radiography Industry 15Global Digital Radiography Industry 16Global Digital Radiography Industry 17Global Digital Radiography Industry 18Global Digital Radiography Industry 19Global Digital Radiography Industry 20Global Digital Radiography Industry 21Global Digital Radiography Industry 22
... for inherited conditions, ROCHESTER, Minn., Sept. 11 ... can be used to regenerate,heart tissue to treat ... was expedited by the editors of Stem Cells ... journal,s Web site at, http://stemcells.alphamedpress.org/ ., The ...
... PURCHASE, N.Y., Sept. 11 Nutrition 21, ... marketer of nutritional supplements under,the Iceland Health ... manage blood sugar levels, improve cardiovascular health, ... today that study results,released by the National ...
Cached Medicine Technology:Stem Cell Regeneration Repairs Congenital Heart Defect 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 2Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 3Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate 4
(Date:9/16/2014)... News) -- Including women older than 70 in national ... reduction in advanced forms of the disease, a new ... programs could result in older women being overdiagnosed and ... to screen older women for breast cancer should be ... of using mass screening, the decision to participate in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Thousands ... against C.R. Bard, Inc. continue to move forward ... District Court, Southern District of West Virginia, Bernstein ... September 15, 2014, the Court has determined that ... the proceeding. The Order indicates that the first ...
(Date:9/16/2014)... Dennis Thompson HealthDay Reporter ... Food and Drug Administration is focusing on the "Low T" ... helping or harming the health of aging American males. ... FDA committees will discuss whether doctors are prescribing testosterone therapy ... hormone increases the risk of stroke and heart attack. ...
(Date:9/16/2014)... researcher Dr. Jeffrey Samet and Dr. Carlos Del ... five year, $5 million grant from the National ... Improving Physician Opioid Prescribing for Chronic Pain in ... most commonly abused substances in the U.S. (after ... now exceed deaths from motor vehicle crashes. Prescription ...
(Date:9/16/2014)... SAMHSA, the federal Substance Abuse and Mental Health Services Administration, ... substance abuse and mental health issues on the communities of ... National Recovery Month, also simply Recovery Month, with its main ... in recovery. It also seeks to educate Americans on ... help those with substance abuse issues live a healthy and ...
Breaking Medicine News(10 mins):Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 2Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 3Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 4Health News:FDA to Probe Testosterone Therapy Claims, Safety 2Health News:FDA to Probe Testosterone Therapy Claims, Safety 3Health News:FDA to Probe Testosterone Therapy Claims, Safety 4Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 2Health News:Narconon Arrowhead Booklet Offers Tips During Recovery Month 3
... the dentist for what you think is a routine checkup ... root canal. Though it,s a term you,ve probably heard before, ... have several questions and feel apprehensive about your upcoming procedure. ... time. The Pennsylvania Dental Association (PDA) wants to help answer ...
... , WASHINGTON, Nov. 12 Over the next several weeks, ... a major step toward improving food safety for all Americans. ... organizations and groups representing victims of foodborne illness is sending ... Safe for the Holidays!" , Every year, millions of Americans ...
... Nov. 12 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly dividend of $.11 per share ... The dividend will be payable December 15, 2009, to ... public in 1984 Mesa Labs has maintained strong cash positions ...
... , WASHINGTON, Nov. 12 Senate Majority Leader Harry Reid ... quality, affordable health care for all. , The Associated Press ... under review is asking individuals who earn more than $250,000 ... tax that goes to Medicare. This measure would bring in ...
... As hormone use declined, so did incidence of abnormal cells ... News) -- Declining use of hormone replacement therapy may be ... a known risk factor for breast cancer, new research suggests. ... found between atypical ductal hyperplasia -- abnormal cells in the ...
... new study published in the November issue of the ... breast cancer patients under 40 years old who undergo fertility ... of their disease when their care is coordinated in a ... surgeons, medical oncologists and reproductive endocrinologists is critical," said Lynn ...
Cached Medicine News:Health News:Painful Root Canals Are a Thing of the Past 2Health News:New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To 'Make Our Food Safe For The Holidays' 2Health News:New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To 'Make Our Food Safe For The Holidays' 3Health News:Reid Moves Toward Progressive Financing Measure to Help Fund Health Care Reform 2Health News:Less HRT, Fewer Cases of Possible Breast Cancer Precursor 2Health News:Less HRT, Fewer Cases of Possible Breast Cancer Precursor 3Health News:Fertility procedures need not delay breast cancer treatment for younger women 2
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... German Craftsmanship have produced ... in the world. Ocutek® ... to you! Only holders ... certificate, which requires and ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: